Researchers discover new ways to ‘turn off’ receptor involved in inflammatory diseases
Discovery could lead to development of new drugs to treat inflammation, coronary artery disease, cancer, more.
Tom Sellers, M.D., M.P.H., newly announced director of the OHSU Knight Cancer Institute, introduces himself to the members of the institute. (OHSU).
OHSU patient Thomas Proctor, 49, of Aloha, Oregon, stretches while jogging a trail near his home. (OHSU/Christine Torres Hicks)